Roche Holding Ltd

As of June 30, 2026, Roche Holding Ltd carries a market capitalization of 270.26B, placing it among publicly traded companies globally. Its enterprise value stands at 296.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Roche Holding Ltd's next confirmed earnings release is scheduled for February 4, 2027.

As of June 30, 2026, Roche Holding Ltd has 796.77M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Roche Holding Ltd maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Roche Holding Ltd's stock has gained approximately 35.65% over the past 52 weeks. The 50-day moving average sits at 369.48, while the 200-day moving average is 350.03.

As of June 30, 2026, Roche Holding Ltd holds 9.73B in cash and equivalents against 31.81B in total debt, resulting in a net debt position of 26.36B. Total book value stands at 32.69B, with working capital of 6.59B providing operational flexibility.

Roche Holding Ltd's most recent stock split took place on May 4, 2001 with a 1:100 split ratio.